#SUMMITtrial
🚨 The #SUMMITtrial finds #Tirzepatide reduces HF events & improves QoL in #HFpEF+#obesity!

📉💙 No significant CV mortality difference. GI side effects noted. A new frontier in HF care? More research needed!🔬 #CardioTwitter @HFSA #MedEd #CardioEd youtu.be/AyKp7AVfj1c?... @americanheart.bsky.social
SUMMIT Trial: Tirzepatide in Heart Failure due to HFpEF & Obesity
YouTube video by MasterMedFacts
youtu.be
February 19, 2025 at 2:59 PM Everybody can reply
1 likes
Why could the #SUMMITtrial compare the intervention (BREO) be compared to placebo... ?

... because existing medications (ADVAIR) has not been shown to benefit patients.

What?!?!

(Also neither trial showed mortality benefit)

@therealemmareid
At #3DCME

@Drug_Evidence
November 27, 2024 at 4:23 PM Everybody can reply